Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ruthven

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Archives of Disease in Childhood|August 1, 1975
Urinary phenolic acid and alcohol excretion in the newbornF Karoum, C R Ruthven, M Sandler
General Pharmacology|August 14, 1998
Resistance of aryl-substituted phenylalanines to decarboxylation in the ratB L Goodwin, C R Ruthven, M Sandler
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1994
Metabolism of dopamine analogues in ratB L Goodwin, C R Ruthven, M Sandler
British Medical Journal|November 14, 1970
Liquor bilirubin levels in normal pregnancy: a reassessment of early prediction of haemolytic diseaseJ Murray, D L Norrie, C R Ruthven
Biochemical Pharmacology|June 15, 1994
Gut flora and the origin of some urinary aromatic phenolic compoundsB L Goodwin, C R Ruthven, M Sandler
Biochemical Pharmacology|December 3, 1993
Phenylpyruvic acid may be a direct precursor of mandelic acid without intermediate transamination of phenylalanineB L Godwin, C R Ruthven, M Sandler
General Pharmacology|April 1, 1997
Metabolism of phenylethanolamines and 2-oxo-2-phenylethylamines in the ratB L Goodwin, C R Ruthven, M Sandler
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 1979
Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illnessM Sandler, C R Ruthven, B L Goodwin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1978
Metabolism of 3, 4-dihydroxyphenylalanine, its metabolites and analogues in vivo in the rat: urinary excretion patternB L Goodwin, C R Ruthven, G S King, et al.
Journal of Neural Transmission|January 1, 1976
In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administrationR D Johnson, C R Ruthven, B L Goodwin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Archives of Disease in Childhood|August 1, 1975
Urinary phenolic acid and alcohol excretion in the newbornF Karoum, C R Ruthven, M Sandler
General Pharmacology|August 14, 1998
Resistance of aryl-substituted phenylalanines to decarboxylation in the ratB L Goodwin, C R Ruthven, M Sandler
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1994
Metabolism of dopamine analogues in ratB L Goodwin, C R Ruthven, M Sandler
British Medical Journal|November 14, 1970
Liquor bilirubin levels in normal pregnancy: a reassessment of early prediction of haemolytic diseaseJ Murray, D L Norrie, C R Ruthven
Biochemical Pharmacology|June 15, 1994
Gut flora and the origin of some urinary aromatic phenolic compoundsB L Goodwin, C R Ruthven, M Sandler
Biochemical Pharmacology|December 3, 1993
Phenylpyruvic acid may be a direct precursor of mandelic acid without intermediate transamination of phenylalanineB L Godwin, C R Ruthven, M Sandler
General Pharmacology|April 1, 1997
Metabolism of phenylethanolamines and 2-oxo-2-phenylethylamines in the ratB L Goodwin, C R Ruthven, M Sandler
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 2, 1979
Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illnessM Sandler, C R Ruthven, B L Goodwin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 1, 1978
Metabolism of 3, 4-dihydroxyphenylalanine, its metabolites and analogues in vivo in the rat: urinary excretion patternB L Goodwin, C R Ruthven, G S King, et al.
Journal of Neural Transmission|January 1, 1976
In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administrationR D Johnson, C R Ruthven, B L Goodwin, et al.
Pageof 2